期刊文献+

室间隔缺损术后反应性肺高压危险因素及疗效分析 被引量:1

The risk factors and management for reactive pulmonary hypertension after corrective surgery of ventricular septal defect
原文传递
导出
摘要 目的探求室是隔缺损、肺高压患儿术后反应性肺高压的发生率、危险因素。评估术后反应性肺高压的治疗效果。方法对1991年至2006期间术前诊断室间隔缺损、肺高压在我科接受室间隔缺损修补术患儿的客观病史资料进行回顾性研究。搜集患儿围术期客观指标进行统计和分析,评估术后早期疗效。探求术后反应性肺高压的危险因素。结果16年间共2141例室间隔缺损合并肺高压的患儿纳入本课题。术后住院早期死亡20例,住院晚期死亡3例,术后病情平稳出院2118例。术后反应性肺高压发生率为6.1%,术后肺高压危象的发生率为2.1%、死亡率为2.3%。术中体外循环时间≥90min(P〈0.01)、主动脉阻断时间≥75min(P%0.01)、术后残余分流(P〈0.01)是发生术后反应性肺高压的相关危险因素。结论室间隔缺损、肺高压的患儿术后反应性肺高压的独立危险因素有:术前年龄、Pp/Ps、存在充血性心力衰竭、术后二尖瓣反流中度以上。术后反应性肺高压的患儿更容易依赖儿茶酚胺类药物,左房途径输入儿茶酚胺类药物能增加其强心效果。 Objective To study the risk factors and management for reactive pulmonary hypertension (RPH) after corrective surgery of ventricular septal defect (VSD) in children. Methods From 1991 to 2006, 2141 patients who underwent corrective surgery for VSD were recruited in this study. The patients" clinical data, including patients" gender, age, diagnosis, the ratio of pulmonary pressure to systolic pressure (Pp/Ps), the time of cardiopulmonary bypass (CPB), postoperative RPH, pul- monary hypertension crisis (PHC) and other complications, and the treatment of RPH, were retro- spectively analyzed. The risk factors of postoperative RPH were statistically analyzed. The outcomes of RPH treatment were also evaluated. Results Twenty patients died during the early in-hospital period, 3 patients died during the late in-hospital period, and the others were recovered after surgery. The mobility of postoperative RPH and PHC were 6. 12% and 2. 06%, respectively. The overall mortality of the patients was 2. 27%. The patients had CPB≥90 rain, aortic clamp time≥75 min, postoperative catecholamines treatment, and residual intracardiac shunting after surgery were more likely to develop postoperative RPH. Conclusions The independent risk factors of postoperative RPH include patients" Pp/Ps ratio, age, congestive heart failure before surgery, moderate mitral regurgitation after surgery. Catecholamines treatment could effectively improve right ventricular function in the patients with RPH.
出处 《中华小儿外科杂志》 CSCD 北大核心 2011年第4期255-261,共7页 Chinese Journal of Pediatric Surgery
关键词 心脏病 先天性 室间隔缺损 危险因素 Heart disease, congenital Ventricular septal defects Risk factor
  • 相关文献

参考文献17

  • 1Rubin LJ,American College of Chest Physicians.Diagnosis and management of pulmonary arterial hypertension:ACCP evidence-based clinical practice guideline.Chest,2004,126 (1Suppl):1S-92S.
  • 2Humbert M,Morrell NW,Archer SL,et al.Cellular and molecular pathobiology of pulmonary arterial hypertension.J Am Coll Cardiol,2004,43(12 Suppl):13S-24S.
  • 3Levy M,Maurey C,Celermajer DS,et al.Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease.J Am Coll Cardiol,2007,49(7):803-810.
  • 4Tuder RM,Marecki JC,Richter A,et al.Pathology of pulmonary hypertension.Clin Chest Med,2007,28 (1):23-42.
  • 5Polderman FN,Cohen J,Blom NA,et al.Sudden unexpected death in children with a previously diagnosed cardiovascular disorder.Int J Cardiol,2004,95(2-3):171-176.
  • 6Lindberg L,Olsson AK,Jogi P,et al.How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg,2002,123(6):1155-1163.
  • 7Huges RJ,Jais X,Bonderman D,et al.The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension.a 1-year follow-up study.Eur Respir J,2006,28(1):138-143.
  • 8McLaughlin W,Archer SL,Badesch DB,et al.ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society,Inc.; and the Pulmonary Hypertension Association.J Am Coll Cardiol,2009,53 (17):1573-1619.
  • 9Henriques-Coelho T,Branāo-Nogueira A,Moreira-Goncalves D,et al.Effects of TNF-alpha blockade in monocrotaline-induced pulmonary hypertension.Rev Port Cardiol,2008,27(3):341-348.
  • 10Kageyama K,Hashimoto S,Nakajima Y,et al.The change of plasma endothelin-1 levels before and after surgery with or without Down syndrome.Paediatr Anaesth,2007,17 (11):1071-1077.

同被引文献13

  • 1苏肇伉,祝忠群.危重婴幼儿先天性心脏病急诊外科技术研究[J].医学研究杂志,2006,35(8):2-4. 被引量:13
  • 2Romosan G,Henriksson E,Rylander A,et al.Diagnostic performance of routine ultrasound screening for feta abnormalities in an unselected swedis population in 2000~2005.Ultrasound Obstet Gynecol,2009,34(5):526-533.
  • 3Nicolaides KH.Increased nuchal translucency with normal karyotype./ Nicolaides KH.The 11 ~ 13th weeks scan.London:Fetal Medicine Foundation,2004.71-94.
  • 4庄建.先天性心脏病防治策略与模式探讨[J].中华医学会心血管外科分会通讯,2008,12(1):3-5.
  • 5Cohen MS,Anderson RH,Cohen MI,et al.Controversies,genetics,diagnostic assessment,and outcomes relating to the heterotaxy syndrome.Cardiol Young,2007,17(suppl 2):2943.
  • 6Mavroudis C,Baker CL.Physiologic versus anatomic repair of congenitally corrected transposition of the great arteries.Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu,2003,6:16-26.
  • 7Reddy VM,McElhinney DB,Amin Z,et al.Early and intermediate outcome after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collecteral arteries:experience with 85 patients.Circulation,2000,101(15):1826-1832.
  • 8d'Udeken Y,Alphoso N,Norgadrd MA,et al.Pulmonary atresia with ventricular septal defects and major aortopulmonary collecteral arteries:unifoculization brings no long-term benefits.J Thorac Cardiovasc Surg,2005,130:1496-502.
  • 9Galantowiez M,Cheathan JP.Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome.Pediatr Cardiol,2005,26(3):190-199.
  • 10徐志伟,蔡晶晶,张海波,郑景浩,严勤,刘锦纷,苏肇伉,丁文祥.先天性纠正型大动脉错位不同手术方法结果的比较[J].中华小儿外科杂志,2011,32(4):243-247. 被引量:2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部